Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets.

Nava M, Dutta P, Zemke NR, Farias-Eisner R, Vadgama JV, Wu Y. Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets. BMC Med Genomics. 2019 02 08; 12(1):32.

View in: PubMed

subject areas

Breast Neoplasms
Cell Line, Tumor
Chromatin
Chromatin Immunoprecipitation
Drug Resistance, Neoplasm
Epidermal Growth Factor
Gene Expression Profiling
Hela Cells
Histones
Humans
Receptor, erbB-2
S100 Proteins
Signal Transduction

authors with profiles

Jaydutt V Vadgama, PhD
Yanyuan Wu, MD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support